Food and Drug Administration (FDA) approved it for this purpose, the FDA didnt recognize it as a safe and effective medication for weight loss until 2021
If weight loss is your goal, youre going to do slightly better with (Liraglutide) too. GLP-1 Agonist Wins 1st Incretin Showdown ******** Lisa Neff and Robert M Kushner, Division of Endocrinology, Metabolism, and Molecular Medicine, Division of General Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL GLP-1 receptor agonists have proven to be a very useful option in the treatment of type 2 diabetes, particularly in overweight and obese patients
While tirzepatide's glucose-lowering effect is glucose-dependent (reducing hypoglycemia risk), the combination with phentermine's metabolic effects requires monitoring
[5] Disclaimer: The products mentioned are not intended for human or animal consumption